Your session is about to expire
← Back to Search
MAVEN Program for Enhancing Diversity in Scientific Leadership
Phase 2
Waitlist Available
Led By Karina Davidson, PhD, MASc
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Awards & highlights
Study Summary
This trial will enroll 160 senior scientists who are members of an underrepresented ethnicity, race, or gender in order to study the effects of the MAVEN intervention on their career satisfaction, productivity, scientific networks, and leadership skills.
Who is the study for?
The MAVEN trial is for scientists who are 10 to 15 years from their terminal degree, have at least one funded R01 level grant, and belong to an ethnicity, race or gender under-represented in senior faculty roles. It's not for those outside the 10-15 year range or who don't meet the diversity criteria.Check my eligibility
What is being tested?
MAVEN is testing an educational program with virtual sessions and mentorship aimed at improving career satisfaction, productivity, networking, and leadership positions among minority senior scientists.See study design
What are the potential side effects?
Since MAVEN is an educational intervention rather than a medical treatment, it does not have physical side effects. However, participants may experience increased workload or stress due to additional commitments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline and yearly afterwards until study completion 5 years following enrollment of the first cohort.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Career Satisfaction
Secondary outcome measures
Academic Productivity
Other outcome measures
Professional Network Size
Scientific Leadership Ascension
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MAVENExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Participants enrolled in the control group will receive no mentoring activities but will complete all study measures and assessments.
Find a Location
Who is running the clinical trial?
Northwell HealthLead Sponsor
460 Previous Clinical Trials
470,883 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,705 Previous Clinical Trials
7,507,126 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
246,952 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not belong to an under-represented group in senior faculty levels.I received my highest degree in my field 10-15 years ago.I belong to an under-represented group in senior faculty levels.I received my highest degree in my field either less than 10 years ago or more than 15 years ago.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: MAVEN
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities for individuals to participate in the trial?
"This research, posted in May 2021 and last updated December 2021, is not currently recruiting. Nevertheless, one other medical trial has begun accepting candidates at this time."
Answered by AI
Has MAVEN been sanctioned by any regulatory organizations?
"Due to MAVEN being in a Phase 2 trial, there is some evidence of safety but no prior clinical data on efficacy. Accordingly, our team at Power assigned it a score of 2."
Answered by AI
Other Trials to Consider
Popular Categories
Popular Guides
Share this study with friends
Copy Link
Messenger